Overview

Using Cryoballoon Ablation as Initial Treatment for Persistent Atrial Fibrillation

Status:
Not yet recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
This study is to assess the effectiveness and safety of using cryoballoon ablation comparing with anti-arrhythmic drug therapy as initial treatment for naive patients with persistent atrial fibrillation.
Phase:
N/A
Details
Lead Sponsor:
Ruijin Hospital
Treatments:
Amiodarone
Anti-Arrhythmia Agents
Dronedarone
Propafenone
Sotalol